Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications.
Mangoni AA, Jackson SH.
Br J Clin Pharmacol. 2004 Jan;57(1):6-14. doi: 10.1046/j.1365-2125.2003.02007.x.
GPCR signaling and cardiac function.
Capote LA, Mendez Perez R, Lymperopoulos A.
Eur J Pharmacol. 2015 Sep 15;763(Pt B):143-8. doi: 10.1016/j.ejphar.2015.05.019. Epub 2015 May 14.
MicroRNAs in cardiovascular disease.
Gurha P.
Curr Opin Cardiol. 2016 May;31(3):249-54. doi: 10.1097/HCO.0000000000000280.
The functions of microRNA-208 in the heart.
Zhao X, Wang Y, Sun X.
Diabetes Res Clin Pract. 2020 Feb;160:108004. doi: 10.1016/j.diabres.2020.108004. Epub 2020 Jan 3.
Cardiac sigma receptors - an update.
Stracina T, Novakova M.
Physiol Res. 2018 Dec 31;67(Suppl 4):S561-S576. doi: 10.33549/physiolres.934052.
Taking microRNAs to heart.
Callis TE, Wang DZ.
Trends Mol Med. 2008 Jun;14(6):254-60. doi: 10.1016/j.molmed.2008.03.006. Epub 2008 May 3.
The vertebrate heart: an evolutionary perspective.
Stephenson A, Adams JW, Vaccarezza M.
J Anat. 2017 Dec;231(6):787-797. doi: 10.1111/joa.12687. Epub 2017 Sep 14.
Class I anti-arrhythmic drugs: structure and function at the cardiac sodium channel.
Sheldon RS, Duff HJ, Hill RJ.
Clin Invest Med. 1991 Oct;14(5):458-65.
MicroRNAs in heart development.
Espinoza-Lewis RA, Wang DZ.
Curr Top Dev Biol. 2012;100:279-317. doi: 10.1016/B978-0-12-387786-4.00009-9.
microRNAs and muscle disorders.
Chen JF, Callis TE, Wang DZ.
J Cell Sci. 2009 Jan 1;122(Pt 1):13-20. doi: 10.1242/jcs.041723.
